New Jersey 2026-2027 Regular Session

New Jersey Assembly Bill A3328

Introduced
1/13/26  

Caption

Prohibits sale of certain products using advertisements alluding to controlled dangerous substances or analogs.

Impact

If enacted, A3328 would modify existing consumer protection laws in New Jersey, establishing that any violation of this bill would be treated as an unlawful practice under the state's consumer fraud act. Offenders could face substantial penalties: a first offense may incur a fine of up to $10,000, while repeat violations could lead to fines of up to $20,000. Additionally, the Attorney General would be empowered to issue cease-and-desist orders against violating products, allowing for a more robust enforcement of consumer protections.

Summary

Assembly Bill A3328 introduces significant regulations regarding the advertisement and sale of products linked to controlled dangerous substances or analogs. The bill seeks to prohibit the sale of any food, beverage, or product intended to be ingested or inhaled that uses advertisements suggesting connections to these substances, particularly to individuals under the age of 18. This reflects a broader concern over the influence of marketing on youth and aims to protect minors from exposure to harmful products.

Contention

Discussion surrounding A3328 is likely to reveal varying perspectives on the balance between protection of youth and the rights of businesses to advertise their products. Opponents may argue that the bill imposes overly stringent limitations on legitimate products and advertisements that do not explicitly promote illegal usage or risks. Proponents, on the other hand, contend that such regulations are necessary to reduce the normalization of dangerous substances in advertisements targeted at young audiences, emphasizing the role of marketing in contributing to substance abuse issues.

Implementation

The bill is anticipated to take effect three months following its enactment, which signals an urgency to address the marketing of products associated with controlled substances. By focusing on advertisements that allude to these substances, A3328 aims not only to curtail existing practices but also to set a precedent for future regulations regarding the intersection of advertising, public health, and youth welfare.

Companion Bills

NJ A366

Carry Over Prohibits sale of certain products using advertisements alluding to controlled dangerous substances or analogs.

NJ S2741

Carry Over Prohibits sale of certain products using advertisements alluding to controlled dangerous substances or analogs.

Similar Bills

CA AB2717

Outdoor advertising displays: arenas: exemptions.

CA SB1050

False advertising: synthetic digital performers.

HI SB2733

Relating To Liquor.

CA AB840

Outdoor advertising displays: redevelopment agency project areas.

CA SB783

Outdoor advertising displays: redevelopment agency project areas.

CA AB770

Advertising displays: City of Los Angeles: exemption: ordinance.

AZ HB2179

Marijuana; advertising; restrictions

CA SB1228

Advertising displays: exemptions: redevelopment agency projects.